These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 23037955)

  • 1. Novel mutation in GJB4 gene (connexin 30.3) in a family with erythrokeratodermia variabilis.
    Sbidian E; Bousseloua N; Jonard L; Leclerc-Mercier S; Bodemer C; Hadj-Rabia S
    Acta Derm Venereol; 2013 Mar; 93(2):193-5. PubMed ID: 23037955
    [No Abstract]   [Full Text] [Related]  

  • 2. Erythrokeratoderma variabilis caused by a recessive mutation in GJB3.
    Fuchs-Telem D; Pessach Y; Mevorah B; Shirazi I; Sarig O; Sprecher E
    Clin Exp Dermatol; 2011 Jun; 36(4):406-11. PubMed ID: 21564177
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel and recurrent connexin 30.3 and connexin 31 mutations associated with erythrokeratoderma variabilis.
    Scott CA; O'Toole EA; Mohungoo MJ; Messenger A; Kelsell DP
    Clin Exp Dermatol; 2011 Jan; 36(1):88-90. PubMed ID: 21188847
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Japanese sporadic case of erythrokeratodermia variabilis caused by the connexin-30.3 (GJB4) mutation: Is Glycine 12 a mutational hotspot in the connexin family?
    Yoshikata-Isokawa Y; Itoh M; Nakagawa H
    J Dermatol; 2016 Jul; 43(7):830-1. PubMed ID: 26826093
    [No Abstract]   [Full Text] [Related]  

  • 5. Mutation analysis of GJB3 and GJB4 in Chinese patients with erythrokeratodermia variabilis.
    Liu H; Liu H; Fu XA; Yu YX; Zhou GZ; Lu XM; Tian HQ; Yu CP; Shi ZX; Yu ML; Zhang FR
    J Dermatol; 2012 Apr; 39(4):400-1. PubMed ID: 21950330
    [No Abstract]   [Full Text] [Related]  

  • 6. Erythrokeratodermia variabilis: report of two cases and a novel missense variant in GJB4 encoding connexin 30.3.
    Kokotas H; Papagiannaki K; Grigoriadou M; Petersen MB; Katsarou A
    Eur J Dermatol; 2012; 22(2):182-6. PubMed ID: 22266302
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel and recurrent mutations in GJB3 and GJB4 cause erythrokeratodermia variabilis et progressiva.
    Dai S; Wang H; Lin Z
    Indian J Dermatol Venereol Leprol; 2020; 86(1):87-90. PubMed ID: 31793497
    [No Abstract]   [Full Text] [Related]  

  • 8. Clinical variability of the GJB4:c.35G > A gene variant: a study of a large Brazilian erythrokeratodermia pedigree.
    de Oliveira RTG; Christofolini DM; Criado PR; Lacaz Martins E; Kelsell D; Machado Filho CDS
    Int J Dermatol; 2020 Jun; 59(6):722-725. PubMed ID: 32311086
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Erythrokeratodermia variabilis et progressiva with a rare GJB3 mutation.
    Imura K; Ikeya S; Ogata T; Tokura Y
    J Dermatol; 2020 Apr; 47(4):e111-e113. PubMed ID: 31912549
    [No Abstract]   [Full Text] [Related]  

  • 10. Genetic heterogeneity in erythrokeratodermia variabilis: novel mutations in the connexin gene GJB4 (Cx30.3) and genotype-phenotype correlations.
    Richard G; Brown N; Rouan F; Van der Schroeff JG; Bijlsma E; Eichenfield LF; Sybert VP; Greer KE; Hogan P; Campanelli C; Compton JG; Bale SJ; DiGiovanna JJ; Uitto J
    J Invest Dermatol; 2003 Apr; 120(4):601-9. PubMed ID: 12648223
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Erythrokeratodermia variabilis et progressiva.
    Ishida-Yamamoto A
    J Dermatol; 2016 Mar; 43(3):280-5. PubMed ID: 26945536
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A missense mutation in the GJB3 gene responsible for erythrokeratodermia variabilis in a Chinese family.
    Wang W; Liu LH; Chen G; Gao M; Zhu J; Zhou FS; Cheng H; Tang HY; Wu BY; Sun LD; Yang S; Wang PG; Zhang XJ
    Clin Exp Dermatol; 2012 Dec; 37(8):919-21. PubMed ID: 22681493
    [No Abstract]   [Full Text] [Related]  

  • 13. A case of erythrokeratodermia variabilis with connexin 31 gene mutation (Cx31F137L).
    Torres T; Velho G; Sanches M; Selores M
    Int J Dermatol; 2012 Apr; 51(4):494-6. PubMed ID: 21913904
    [No Abstract]   [Full Text] [Related]  

  • 14. Erythrokeratodermia variabilis et progressiva due to a novel mutation in GJB4.
    Zhang X; Xu P; Lu J; Ding Y; Gu J; Shi Y
    Exp Dermatol; 2022 Apr; 31(4):594-599. PubMed ID: 34717022
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Familial erythrokeratodermia variabilis with pustular lesions: a new variant?
    Zhang L; Huo W; Gao XH; Ma L; Xiu Y; Zheng S; Hong Y; Chen HD
    Acta Derm Venereol; 2010 May; 90(3):274-8. PubMed ID: 20526545
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The novel GJB3 mutation p.Thr202Asn in the M4 transmembrane domain underlies erythrokeratodermia variabilis.
    Sugiura K; Arima M; Matsunaga K; Akiyama M
    Br J Dermatol; 2015 Jul; 173(1):309-11. PubMed ID: 25556823
    [No Abstract]   [Full Text] [Related]  

  • 17. Two de novo GJA1 mutation in two sporadic patients with erythrokeratodermia variabilis et progressiva.
    Li C; Liang J; Chen P; Zeng K; Xue R; Tian X; Liang L; Wang Q; Shi M; Zhang X
    Mol Genet Genomic Med; 2019 Jun; 7(6):e670. PubMed ID: 30924322
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An unusual missense mutation in the GJB3 gene resulting in severe erythrokeratodermia variabilis.
    Glatz M; van Steensel MA; van Geel M; Steijlen PM; Wolf P
    Acta Derm Venereol; 2011 Oct; 91(6):714-5. PubMed ID: 21879244
    [No Abstract]   [Full Text] [Related]  

  • 19. Exome sequencing identifies novel compound heterozygous mutations in GJB3 gene that cause erythrokeratodermia variabilis et progressiva.
    Deng Y; Wang H; Mou Y; Zeng Q; Xiong X
    Australas J Dermatol; 2019 Feb; 60(1):e87-e89. PubMed ID: 29992552
    [No Abstract]   [Full Text] [Related]  

  • 20. A novel GJB3 (Cx31) missense mutation in a Chinese patient with erythrokeratodermia variabilis.
    Wang ZX; Lu WS; Li H; Lin D; Zhou FS; Sun LD; Yang S; Zhang XJ
    J Eur Acad Dermatol Venereol; 2011 Jan; 25(1):113-5. PubMed ID: 20497287
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.